EyeVision Pharma
- Biotech or pharma, therapeutic R&D
EyeVision Pharma’s (EP’s) mission is to end the myopia epidemic. EP is seeking investment and partnering opportunities to develop ocular restricted combination therapies to inhibit the axial elongation of the eye, the underlying cause for the pathogenesis and progression of myopia.
Address
New YorkNew York
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}